Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders Equity (Deficiency)

v3.10.0.1
Consolidated Statements of Changes in Stockholders Equity (Deficiency) - USD ($)
Common Stock
Additional Paid-In Capital
Accumlated Other Comprehensive Income
Accumulated Deficit
Total
Beginning Balance, Shares at Dec. 31, 2016 74,011,188        
Beginning Balance, Amount at Dec. 31, 2016 $ 7,402 $ 14,165,361 $ (416,631) $ 11,263,540 $ 2,492,628
Shares issued for services, shares 125,000        
Stock issued for services $ 13 23,237     23,250
Imputed interest on stock advances   26,753     26,753
Beneficial conversion value of debt   39,231     39,231
Common stock issued with debentures        
Foreign currency translation adjustment     166,304   166,304
Net income (loss)       1,365,884 1,365,884
Ending Balance, Shares at Dec. 31, 2017 74,143,590        
Ending Balance, Amount at Dec. 31, 2017 $ 7,415 14,254,582 (250,327) (9,897,620) 4,114,050
Imputed interest on stock advances   1,514     1,514
Adoption of ASU 2017-11   287,881   (64,966) 222,915
Shares issued for warrants, shares 201,088        
Shares issued for warrants $ 20 (20)    
Common stock issued with debentures, shares 1,831,220        
Common stock issued with debentures $ 183 582,303     582,486
Foreign currency translation adjustment   2,585,569     2,585,569
Warrants issued with debt 2,951,429     2,951,429
Common stock issued for the purchase of subsidiaries,shares 1,404,400        
Common stock issued for the purchase of subsidiaries $ 140 5,587,534     5,587,674
Purchase of treasury stock, shares (2,040,000)        
Purchase of treasury stock $ (204) (2,260,770)     (2,260,974)
Foreign currency translation adjustment   (33,713) (831,011)   (864,724)
Net income (loss)       (3,046,308) (3,046,308)
Ending Balance, Shares at Dec. 31, 2018 75,540,298        
Ending Balance, Amount at Dec. 31, 2018 $ 7,555 $ 23,956,309 $ (1,081,338) $ (13,008,894) $ 9,873,632